These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33803299)

  • 1. Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy.
    Polvere I; Parrella A; Casamassa G; D'Andrea S; Tizzano A; Cardinale G; Voccola S; Porcaro P; Stilo R; Vito P; Zotti T
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33803299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
    Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
    Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
    Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
    Front Public Health; 2021; 9():628098. PubMed ID: 34249830
    [No Abstract]   [Full Text] [Related]  

  • 6. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.
    Ho HL; Wang FY; Lee HR; Huang YL; Lai CL; Jen WC; Hsieh SL; Chou TY
    Lancet Reg Health West Pac; 2020 Oct; 3():100041. PubMed ID: 34173603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
    Guo CC; Mi JQ; Nie H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
    Leone V; Meisinger C; Temizel S; Kling E; Gerstlauer M; Frühwald MC; Burkhardt K
    PLoS One; 2022; 17(8):e0272874. PubMed ID: 35951611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and diagnostic accuracy of serology for COVID-19.
    Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
    BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.
    Alharbi SA; Almutairi AZ; Jan AA; Alkhalify AM
    Cureus; 2020 Sep; 12(9):e10285. PubMed ID: 33047077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave.
    Candoni A; Petruzzellis G; Sperotto A; Andreotti V; Giavarra M; Corvaja C; Minisini A; Comuzzi C; Tascini C; Fanin R; Fasola G
    PLoS One; 2022; 17(2):e0262784. PubMed ID: 35108300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.
    Rosado J; Pelleau S; Cockram C; Merkling SH; Nekkab N; Demeret C; Meola A; Kerneis S; Terrier B; Fafi-Kremer S; de Seze J; Bruel T; Dejardin F; Petres S; Longley R; Fontanet A; Backovic M; Mueller I; White MT
    Lancet Microbe; 2021 Feb; 2(2):e60-e69. PubMed ID: 33521709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
    Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D;
    Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
    Batchi-Bouyou AL; Lobaloba Ingoba L; Ndounga M; Vouvoungui JC; Mfoutou Mapanguy CC; Boumpoutou KR; Ntoumi F
    Int J Infect Dis; 2021 May; 106():3-7. PubMed ID: 33370565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two SARS-CoV-2 IgG/IgM Rapid Tests in Capillary Blood Samples.
    Lee NY; Ham JY; Hwang N; Song KE
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
    Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.